"How it works: The site features discounts that the Trump administration has negotiated with drug companies, including Pfizer, AstraZeneca, Eli Lilly and Novo Nordisk. People can't buy drugs directly from the site. Instead, it's a landing page with links that take them to pharmaceutical companies' direct-to-consumer purchasing platforms, or coupons that can be presented at a pharmacy. People who have health insurance could still pay cash for a medication from the site."
"Between the lines: The platform is part of a broader push to move some patients to cash purchases. That allows drug companies to selectively discount certain medicines but still keep prices for other drugs high. Trump struck drug pricing deals with the participating drug companies that included listing selected medications on TrumpRx. The administration hasn't disclosed specifics of the deals, citing their confidential nature. Democrats in Congress have raised concerns about the legality of TrumpRx and potential conflicts of interest."
"Democrats in Congress have raised concerns about the legality of TrumpRx and potential conflicts of interest. The platform could make blockbusterGLP-1 drugs more accessible, since many insurers don't cover the pricey medications for weight-loss. For example, Eli Lilly and Novo Nordisk's GLP-1 injections are available on TrumpRx starting at $199. Oral GLP-1 tablets for obesity will be available at $149 for a starting dose per month."
TrumpRx features negotiated discounts from major drugmakers and functions as a landing page linking to manufacturers' direct-purchase platforms or pharmacy coupons. Consumers cannot buy medications directly on the site; they are directed to company purchasing systems or given coupons to present at pharmacies. Cash purchases through the platform may not count toward insurance deductibles or out-of-pocket maximums. The program advances a shift toward cash payment models that let companies selectively discount some medicines while keeping others expensive. The administration kept deal details confidential, and lawmakers raised legality and conflict-of-interest concerns. GLP-1 weight-loss drugs are listed at reduced prices.
Read at Axios
Unable to calculate read time
Collection
[
|
...
]